P2Y receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Arch Oral Biol

Department of Biochemistry and Christopher S. Bond Life Sciences Center, University of Missouri, 1201 Rollins St., Columbia, MO, 65211-7310, USA.

Published: April 2021

Objective: Sjögren's syndrome (SS) is a chronic autoimmune exocrinopathy characterized by lymphocytic infiltration of the salivary and lacrimal glands and decreased saliva and tear production. Previous studies indicate that the G protein-coupled P2Y nucleotide receptor (P2YR) is upregulated in numerous models of salivary gland inflammation (i.e., sialadenitis), where it has been implicated as a key mediator of chronic inflammation. Here, we evaluate both systemic and localized P2YR antagonism as a means to resolve sialadenitis in the NOD.H-2,IFNγ,CD28 (NOD.H-2 DKO) mouse model of SS.

Design: Female 4.5 month old NOD.H-2 DKO mice received daily intraperitoneal injections for 10 days of the selective P2YR antagonist, AR-C118925, or vehicle-only control. Single-dose localized intraglandular antagonist delivery into the Wharton's duct was also evaluated. Carbachol-induced saliva was measured and then submandibular glands (SMGs) were isolated and either fixed and paraffin-embedded for H&E staining, homogenized for RNA isolation or dissociated for flow cytometry analysis.

Results: Intraperitoneal injection, but not localized intraglandular administration, of AR-C118925 significantly enhanced carbachol-induced salivation and reduced lymphocytic foci and immune cell markers in SMGs of 5 month old NOD.H-2 DKO mice, compared to vehicle-injected control mice. We found that B cells represent the primary immune cell population in inflamed SMGs of NOD.H-2 DKO mice that express elevated levels of P2YR compared to C57BL/6 control mice. We further demonstrate a role for P2YRs in mediating B cell migration and the release of IgM.

Conclusion: Our findings suggest that the P2YR represents a novel therapeutic target for the treatment of Sjögren's syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958986PMC
http://dx.doi.org/10.1016/j.archoralbio.2021.105067DOI Listing

Publication Analysis

Top Keywords

nodh-2 dko
16
sjögren's syndrome
12
dko mice
12
mouse model
8
month nodh-2
8
localized intraglandular
8
immune cell
8
control mice
8
p2yr
5
mice
5

Similar Publications

In recognition of accelerating health care spending and alignment with the American College of Physicians (ACP) principles of promoting high-value care, the ACP Clinical Guidelines Committee (CGC) developed a framework to standardize its approach to identifying, appraising, and considering economic evidence in the development of ACP clinical guidelines. This article presents the CGC's process for incorporating economic evidence, which encompasses cost-effectiveness analyses, economic outcomes in randomized controlled trials, and resource utilization (intervention cost) data. Economic evidence is one component of ACP recommendations.

View Article and Find Full Text PDF
Article Synopsis
  • Proteoglycans like biglycan (Bgn) and decorin (Dcn) are crucial for bone health, primarily by attracting water through their unique structures, but their specific functions are not fully understood.
  • Research using knockout mouse models revealed that Bgn deficiency leads to significant bone loss and reduced resilience, while Dcn appears to have a less pronounced impact, although it compensates when Bgn is absent.
  • Both Bgn and Dcn are essential for important signaling pathways in bone maintenance, with Bgn playing a dominant role in preserving bone structure and hydration levels.
View Article and Find Full Text PDF

Background/aim: Gangliosides regulate bone formation and resorption. Bone formation is reduced in mice lacking ganglioside GM2/GD2 synthase due to a decrease in osteoblasts. However, the effects of the loss of complex gangliosides by the deletion of both GM2/GD2 and GD3 synthases are unknown.

View Article and Find Full Text PDF

Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon-γ-mediated pathway.

Am J Transplant

December 2024

The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425. Electronic address:

As important immune regulatory cells, whether innate lymphoid cells (ILCs) are involved in liver transplantation (LT) remains unclear. In a murine orthotopic LT model, we dissected roles of ILCs in liver ischemia-reperfusion injury (IRI). Wild type (WT) grafts suffered significantly higher IRI in Rag2-γc double knockout (DKO) than Rag2 KO recipients, in association with downregulation of group 1 ILCs genes, including IFN-γ.

View Article and Find Full Text PDF

Background: Wild-type (WT) mice fed a conventional high-fat/high-sucrose diet (HFHSD) rarely develop metabolic dysfunction-associated steatohepatitis (MASH) with HCC. Because mouse bile acid (BA) is highly hydrophilic, we hypothesized that making it hydrophobic would lead to MASH with HCC.

Methods: Eleven-week-old WT and Cyp2a12/Cyp2c70 double knockout (DKO) mice were divided into two groups, including one which was fed a normal chow diet, and one which was fed an HFHSD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!